DocDollars

Osiris Therapeutics Inc.

MD · United States · Reporting entity ID 100000136556

Total reported 2019–2025
$1.11M
#1,266 of 2,960 reporting companies — 0% of all reported industry payments
$697K in general payments across 5,405 records, plus $413K in research funding across 29 records.

How it breaks down

General payments $696,850
Research funding $413,276

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Osiris Therapeutics Inc. reported $1.11M to US doctors and teaching hospitals from 2019 to 2025, ranking #1,266 of 2,960 reporting companies. 37% of that was research funding and 63% general payments such as consulting, speaking, food and travel. 5,405 general payment records and 29 research records were filed.

Common questions about Osiris Therapeutics Inc.

How much has Osiris Therapeutics Inc. paid US doctors?

Osiris Therapeutics Inc. reported $1,110,126 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $696,850 in general payments, $413,276 in research funding.

How does Osiris Therapeutics Inc. rank among drug and device companies?

It ranks #1,266 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Osiris Therapeutics Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.